ALFA Finder| Management target | Revenue 100.0% 4 years |
|---|
| Revenue growth | 33% YoY overall; 24% on like-to-like organic basis. |
|---|---|
| Margins | EBITDA margins at 28.6%; targeting 24-25% pre-Ind AS exit rate. |
| Order book | Visibility on 1,200 additional beds under various stages of development. |
| Demand visibility | Strong; 25% growth in outpatient consultations and 28% in discharges. |
| Management confidence | High; citing proven model and hub-and-spoke expansion strategy. |
Growth
Revenue grew 33% YoY to INR 470cr; EBITDA grew 30% to INR 134.6cr; PAT rose 16% to INR 62.5cr.
Outlook
Capex plan of INR 2,200cr to add 2,500 beds by FY32; entering Mumbai (Malad) and NCR; guidance for 20% revenue growth.
Risks
Temporary margin pressure from aggressive new hospital commissioning; regional seasonality; high cost structures in premium markets like Mumbai.
Last quarter's promises, checked
Delivered
- Guided 20% revenue growth → delivered 33% (= BEAT)
- Guided 20% growth in current year → delivered 33% (= BEAT)
- Guided focus on occupancy improvement → delivered 28% discharge growth (= BEAT)
Partly delivered
- Guided maintaining margins → delivered 28.6% vs 32% previous year (= PARTIAL)
Investor Presentation filed with BSE, NSE: RAINBOW. Summary written with AI assistance from the document.
Rainbow Childrens Medicare Ltd: key numbers
- Share price
- ₹1,284.50
- Market cap
- ₹13,046 Cr
- Revenue (annual)
- ₹1,703 Cr
- Net profit (annual)
- ₹278.3 Cr
- P/E (TTM)
- 44.6×Sector 54.5×
- Promoter holding
- 49.83%-0.01% QoQ
- FII holding
- 14.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rainbow Childrens Medicare Ltd
All →Rainbow Childrens Medicare Earnings Call Transcript: Key Takeaways
Rainbow delivered robust 23.2% revenue growth despite a soft monsoon impacting seasonal pediatric volumes.
- Call
- Guides 18% growth
Rainbow Childrens Medicare Results Update
Rainbow Children's Medicare reported Q2 FY27 revenue of Rs. 5,480 Mn, up 23% YoY, with PAT of Rs. 839 Mn. Nellore and Guntur hospitals commenced operations during the quarter.
- hospital beds
- 120.0 beds
Rainbow Childrens Medicare Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹548 Cr (+23% YoY) and PAT ₹84 Cr (+11%). Post-IndAS EBITDA margin fell to 31.0% from 33.5%. Strategy is hub-and-spoke pediatric and maternity expansion across 26 hospitals.
Rainbow Childrens Medicare Q2 FY27 Results: Net Profit ₹83.9 Cr, Up 11.0% YoY
Rainbow Childrens Medicare Ltd reported revenue from operations of ₹548 Cr (+23.2% YoY) and net profit of ₹83.9 Cr (+11.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹83.9 Cr · +11.0% YoY
Rainbow Childrens Medicare Board Meeting Date
Rainbow Children's Medicare will hold a board meeting on 31-Oct-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the results.
Rainbow Childrens Medicare Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.